Role of Comorbidities in Chronic Heart Failure Study

CompletedOBSERVATIONAL
Enrollment

205

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 20, 2018

Study Completion Date

December 20, 2018

Conditions
Heart FailureComorbidityOsteoporosisPulse Wave AnalysisBlood Pressure Monitoring, AmbulatoryOsteoporotic Fractures
Interventions
RADIATION

X-ray of the spine

Every participant will undergo X-ray of the spine so that vertebral fractures can be quantified using the Genant score.

PROCEDURE

Ambulatory blood pressure monitoring (ABPM)

ABPM will be performed using the brachial, oscillometric, automated self-measurement mobil-O-Graph device (I.E.M. GmbH, Stolberg, Germany) with integrated ARCSolver®-Software (Austrian Institute of Technology Wien).

RADIATION

Dual X-ray absorptiometry

Individual bone mineral density and T-Score will be determined by X-ray absorptiometry.

PROCEDURE

Non-invasive procedures

Other non-invasive study procedures include structured patient interview, sampling of blood, buffy coat and spot urine (including biobanking), electrocardiogram, pulse wave velocity and analysis, transthoracic echocardiography, 4-meter gait speed test, hand grip test, questionnaires

Trial Locations (1)

8010

Medical University of Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT02922478 - Role of Comorbidities in Chronic Heart Failure Study | Biotech Hunter | Biotech Hunter